What is the controversy surrounding EDTA chelating therapy?

Chelarage therapy is a legitimate and effective treatment of heavy metal poisoning, especially lead lead, mercury and arsenic poisoning. Ethyleneminetetracetic acid, or EDTA, is a chelate used to treat lead poisoning. The controversy surrounding EDTA chelarage therapy comes from the statement that it can also be used to treat certain other conditions or diseases, despite the fact that the United States states that these statements are unfounded and not approved. When gluing occurs, heavy metal becomes soluble in water, which makes it easy to secrete from the body. The use of heavy metal chelatations began during the First World War when used to clean gas on the basis of arsenic from the system. The current use includes the treatment of plutonium, uranium and iron. After World War II, to treat lead poisoning in those who exceeded the hulls of the boat. This chelating agent remains commonly used to treat lead poisonY heavy metal, including dimeraptosukinic acid (DMSA) and alpha lipo (ala), all of which cause less side effects than previously developed substances. Recently, however, there has been a controversy surrounding EDTA chelating therapy for use other than which it was developed.

The controversy surrounding the chelating therapy EDTA comes mainly from the statement that it can be used to treat atherosclerosis or harvest the arteries, the forerunner of heart disease. Proponents of this type of chelating therapy claim that EDTA can connect with elements in plaque that causes hardened arteries and transmit them from the body in the same way as heavy metals from blood speech would carry. The controversy surrounding the therapy of EDTA Chelative therapy is strengthened by the fact that US food and drug administration states that there is no reliable evidence that EDTA chelarage therapy works in the treatment of atherosclerosis, so the FDA has not given consent to treatmentu.

Another element of controversy surrounding the EDTA chelarage therapy is its use to treat the supposed mercury poisoning. Those who use this therapy claim that the mercury from the dental amalgam used for silver fillings is absorbed into the system and causes long -term accumulation of the element. They also quote the use of mercury as preservatives in various types of children's vaccination. The presence of mercury in the system is then accused of many problems, including autism. Despite the ongoing evidence of the FDA and other organizations that these claims are false, the discussion about Chelling Edta therapy continues.